Malaysia to Buy 12.8 Million Doses of Pfizer's Covid-19 Vaccine
November 27 2020 - 6:16AM
Dow Jones News
By Chester Tay
Malaysia has signed an agreement to procure a Covid-19 vaccine
from Pfizer (Malaysia) Sdn. Bhd. to immunize 6.4 million of its
citizens.
A planned 12.8 million doses of the vaccine will be supplied in
four batches through 2021, Prime Minister Muhyiddin Yassin said
Friday.
He said the government has also signed another agreement with
the COVAX Facility to procure enough vaccines for 10% of the
country's population.
The COVAX Facility is a mechanism established by Gavi, the
Vaccine Alliance, the Coalition for Epidemic Preparedness
Innovations and the World Health Organization to provide early
access to Covid-19 candidate vaccines.
Mr. Muhyiddin said the government will also conduct the third
phase of a clinical test for a Covid-19 vaccine developed by the
Institute of Medical Biology Chinese Academy of Medical Sciences
via a government-to-government initiative with China.
He said this clinical test in Malaysia involving 3,000
participants will commence in December, and assured that it will be
conducted in compliance with the Ministry of Health's
guidelines.
Write to Chester Tay at chester.tay@wsj.com
(END) Dow Jones Newswires
November 27, 2020 06:01 ET (11:01 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Sep 2023 to Sep 2024